Navigation Links
Research explores lung cancer among pediatric cancer patients
Date:11/1/2010

Because primary lung adenocarcinoma is exceedingly rare in the pediatric population, it is difficult to properly classify certain lung tumors in children and adolescents. While anecdotal reports of pediatric patients with lung cancer lesions exist, little research has been conducted to link the disease in children to similar pulmonary malignancies in adults. Through an assessment of clinical, tissue-based and molecular data for pediatric lung cancer, research published in the November edition of the Journal of Thoracic Oncology determined that pulmonary lesions found in young patients with pediatric cancers can be histologically indistinguishable from lung adenocarcinoma seen in adults. Findings indicate that lung adenocarcinomas could occur prior to chemotherapy treatment for a second cancer, and some tumors display gene mutations in EGFR and KRAS this is the first documentation of these mutations in pediatric adenocarcinoma.

Until now, it had seemed reasonable to consider these rare pulmonary tumors as secondary malignancies in children, caused by treatment for other cancers. In this newly published study (the largest study of its kind), however, the tumors of eight patients between the age of 10 and 24 years, all never smokers, were evaluated in terms of histopathologic and molecular data.

Researchers determined that these tumors are (1) adenocarcinomas ranging from bronchioloalveolar carcinoma (BAC), or adenocarcinoma in situ (AIS), to invasive histologic patterns and (2) may be present before administration of chemotherapy for the underlying malignancy, and therefore are not always or necessarily secondary malignancies, as had been previously believed. This study clearly documents the invasive patterns of lung cancer in pediatric cancer patients and suggests that the simultaneous presence of a primary malignancy and pulmonary adenocarcinoma may reflect more than coincidence.

"In the past, because of the unusually young age, we were reluctant to call such tumors 'BAC' and instead qualified these cases as 'BAC-like nodule,'" explained lead investigator, Dr. Marc Ladanyi of Memorial Sloan-Kettering Cancer Center. "Our findings now confirm the presence of EGFR and KRAS mutations in some of these pediatric lung cancers in a proportion similar to lung cancers seen in adults, which allows us to more confidently propose that this is genuine lung cancer in the pediatric population. The clinical course of these lung adenocarcinomas in children remains unclear because all 8 patients had their lung tumors fully removed without subsequent recurrence. This may reflect the fact that half of the patients had AIS, which is now recognized to have a 100 percent disease free survival for completely resected cases. An open question is whether these lung adenocarcinomas are increasing in the pediatric age group or is this due to a detection bias due to more detailed lung imaging in patients with common, non-pulmonary, childhood cancers."


'/>"/>

Contact: Kaitlin Doody
kdoody@spectrumscience.com
202-587-2553
International Association for the Study of Lung Cancer
Source:Eurekalert

Related medicine news :

1. Embedded Mobile & M2M Device revenues to Rise to Almost $19 Billion Globally by 2014, Says Juniper Research
2. 2010 HSR Impact Award recognizes surgical safety research
3. MSU launches first anti-counterfeiting research program
4. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
5. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
6. Researchers discover new way to kill pediatric brain tumors
7. Family Research Council: Planned Parenthood Report Oversexualizes Ten-Year-Olds, Undermines Parental Authority
8. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
9. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
10. International Diabetes Federation awards $2 million to 9 global diabetes research projects
11. Gladstones Robert Mahley to receive Research!America advocacy award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... Fresenius Vascular ... in minimally invasive techniques to treat and manage a wide range of vascular conditions, ... rebranding initiative. With more than 65 centers represented by more than 40 local brands, ...
(Date:6/20/2017)... ... June 20, 2017 , ... MindTouch , the leading ... proud to announce Touchpoints integrations. MindTouch Touchpoints easily integrate product documentation ... to provide a seamless customer experience. , Truly “plug and play,” Touchpoints are ...
(Date:6/20/2017)... ... June 20, 2017 , ... New, state-of-the-art magnetic ... is providing physicians with advanced capabilities for diagnosing and treating disease. , ... enabling doctors to get a more accurate look inside the patient’s body. The ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... systems industry has been selected as the partner of choice by Amtrak to ... railroad service that provides medium- and long-distance intercity service in the contiguous United ...
(Date:6/20/2017)... Pass, OR (PRWEB) , ... June 20, 2017 ... ... Recently, on her nationally syndicated radio program, The Sharon Kleyne Hour Power of ... EyeMist®, Kleyne launched right in to the world’s water crisis and how it ...
Breaking Medicine News(10 mins):
(Date:6/2/2017)... -- NxStage Medical, Inc. (Nasdaq:  NXTM), a leading medical technology company focused ... positive biochemical outcomes related to more frequent hemodialysis with ... be presented at the ERA-EDTA Congress being held June ... The research was conducted by the ... Europe (KIHDNEy) Cohort team with ...
(Date:5/30/2017)... , May 30, 2017 Therapix Biosciences ... Company specializing in the development of cannabinoid-based drugs, ... a company overview at three upcoming scientific and ... Annual LD Micro Invitational: ... Date:                     ...
(Date:5/24/2017)...  ivWatch LLC today announced the launch of ... enable seamless integration of ivWatch,s groundbreaking IV infiltration ... and other devices. By integrating ivWatch technology into ... health care customers deliver a higher level of ... therapy. "The ivWatch OEM Board provides ...
Breaking Medicine Technology: